Valuation: GC Corp.

Market Cap 41TCr 31Cr 27Cr 26Cr 23Cr 44Cr 2.92TCr 44Cr 306.76Cr 120.02Cr 1.52TCr 115.52Cr 113.07Cr 4.87TCr P/E 2024
33.4x
P/E 2025 -10.6x
Enterprise Value 1,80800Cr 134.48Cr 120.04Cr 111.57Cr 101.48Cr 190.93Cr 13TCr 194.37Cr 1.34TCr 524.36Cr 6.65TCr 504.68Cr 493.99Cr 21TCr EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
43.96%
Yield 2024
2.89%
Yield 2025 1.88%
1 day-3.29%
1 week-6.56%
Current month-4.21%
1 month-5.60%
3 months-6.37%
6 months-34.88%
Current year-42.78%
1 week 8,990
Extreme 8990
9,890
1 month 8,990
Extreme 8990
10,150
Current year 8,630
Extreme 8630
18,010
1 year 8,630
Extreme 8630
18,010
3 years 8,630
Extreme 8630
18,490
5 years 8,630
Extreme 8630
31,150
10 years 8,630
Extreme 8630
56,300
Manager TitleAgeSince
Chief Executive Officer 52 01/03/2010
Chief Executive Officer 72 25/03/2010
Corporate Officer/Principal 43 -
Director TitleAgeSince
Chairman 72 17/12/2010
Director/Board Member 76 01/03/2009
Director/Board Member 52 01/03/2010
Date Insider Type Main position Quantity % Market Cap. Importance
25/04/25 Buy

Chief Executive Officer

1,334 0.0028%
25/04/25 Buy

Chief Executive Officer

3,191 0.0068%
25/04/25 Buy

Chief Executive Officer

6,748 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-3.29%-6.56%-41.34%-35.16% 31Cr
+3.55%+7.01%+51.42%+105.45% 1,11600Cr
-0.25%-1.25%+32.49%+61.48% 61TCr
+0.59%+4.03%+25.28%+91.54% 50TCr
-1.48%+1.97%+72.62%+39.59% 36TCr
+2.37%+7.66%+33.65%+48.87% 37TCr
+2.64%+6.95%+21.01%+43.85% 29TCr
+3.24%+6.78%+0.43%+15.71% 26TCr
+1.86%+6.53%+45.98%+52.77% 23TCr
+2.49%+6.98%+33.03%+102.67% 20TCr
Average +1.17%+4.08%+27.46%+52.68% 39.3TCr
Weighted average by Cap. +1.77%+4.93%+38.56%+71.81%

Financials

2024 2025
Net sales 2,20500Cr 164.02Cr 146.41Cr 136.07Cr 123.77Cr 232.86Cr 16TCr 237.06Cr 1.63TCr 639.52Cr 8.11TCr 615.52Cr 602.48Cr 26TCr 2,45100Cr 182.37Cr 162.78Cr 151.29Cr 137.62Cr 258.91Cr 17TCr 263.58Cr 1.82TCr 711.05Cr 9.01TCr 684.37Cr 669.87Cr 29TCr
Net income 2.4TCr 1.79Cr 1.6Cr 1.48Cr 1.35Cr 2.54Cr 169.28Cr 2.58Cr 18Cr 6.97Cr 88Cr 6.71Cr 6.56Cr 282.62Cr -6.95TCr -5.17Cr -4.62Cr -4.29Cr -3.9Cr -7.34Cr -489.78Cr -7.47Cr -52Cr -20Cr -255.55Cr -19Cr -19Cr -817.73Cr
Net Debt 1,04200Cr 78Cr 69Cr 64Cr 58Cr 110.05Cr 7.34TCr 112.04Cr 772.48Cr 302.24Cr 3.83TCr 290.9Cr 284.74Cr 12TCr 1,39400Cr 103.7Cr 93Cr 86Cr 78Cr 147.23Cr 9.82TCr 149.88Cr 1.03TCr 404.33Cr 5.12TCr 389.16Cr 380.92Cr 16TCr
Projected Income Statement - Annual - GC Corp.
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
142
Date Price Change Volume
15/26/15 ₩9,110.00 -3.29% 71,855
14/26/14 ₩9,420.00 -0.95% 24,122
13/26/13 ₩9,510.00 -0.73% 72,592
12/26/12 ₩9,580.00 -1.74% 55,985
08/26/08 ₩9,750.00 -1.91% 54,327
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock